TAMMY GRIFFIS: Open Payments
NPI 1407251267 · TREZEVANT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 51 payments from 8 companies in 2025. Trend: 2023 $492 · 2024 $499 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $436 |
| ABBVIE INC. | 21 | $254 |
| Abbott Laboratories | 3 | $198 |
| BETA BIONICS, INC. | 2 | $100 |
| Lundbeck LLC | 2 | $39 |
| Organon LLC | 1 | $33 |
| CeQur Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: Auvelity, VRAYLAR, FREESTYLE LIBRE 3, iLet Bionic Pancreas, NEXPLANON, VYEPTI, REXULTI, CeQur Simplicity.
Industry payments across TN — which companies pay providers there.
